Statin therapy decreases N-terminal pro-B-type natriuretic peptide in HIV: Randomized placebo-controlled trial

Sahera Dirajlal-Fargo; Bruce Kinley; Ying Jiang; Chris T. Longenecker; Corrilynn O. Hileman; Sara Debanne; Grace A. McComsey

doi:10.1097/QAD.0000000000000547

Statin therapy decreases N-terminal pro-B-type natriuretic peptide in HIV: Randomized placebo-controlled trial

Sahera Dirajlal-Fargo, Bruce Kinley, Ying Jiang, Chris T. Longenecker, Corrilynn O. Hileman, Sara Debanne, Grace A. McComsey^*

^*Corresponding author for this work

Pediatrics

Research output: Contribution to journal › Article › peer-review

19 Scopus citations

Abstract

Objective: HIV-infected participants are at a higher risk for cardiovascular disease (CVD). N-terminal pro-B-type natriuretic peptide (NT-proBNP) is a significant predictor of CVD in the general population and is associated with mortality in HIV.

Original language	English (US)
Pages (from-to)	313-321
Number of pages	9
Journal	AIDS
Volume	29
Issue number	3
DOIs	https://doi.org/10.1097/QAD.0000000000000547
State	Published - Nov 11 2014

Funding

Keywords

Cardiovascular disease
Inflammation
N-terminal pro-B-type natriuretic peptide
Statin therapy

ASJC Scopus subject areas

Infectious Diseases
Immunology and Allergy
Immunology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1097/QAD.0000000000000547

Cite this

@article{d9d08416ed834e19ad7df3ac520cb0db,

title = "Statin therapy decreases N-terminal pro-B-type natriuretic peptide in HIV: Randomized placebo-controlled trial",

abstract = "Objective: HIV-infected participants are at a higher risk for cardiovascular disease (CVD). N-terminal pro-B-type natriuretic peptide (NT-proBNP) is a significant predictor of CVD in the general population and is associated with mortality in HIV.",

keywords = "Cardiovascular disease, Inflammation, N-terminal pro-B-type natriuretic peptide, Statin therapy",

author = "Sahera Dirajlal-Fargo and Bruce Kinley and Ying Jiang and Longenecker, {Chris T.} and Hileman, {Corrilynn O.} and Sara Debanne and McComsey, {Grace A.}",

year = "2014",

month = nov,

day = "11",

doi = "10.1097/QAD.0000000000000547",

language = "English (US)",

volume = "29",

pages = "313--321",

journal = "AIDS",

issn = "0269-9370",

publisher = "Lippincott Williams and Wilkins",

number = "3",

}

TY - JOUR

T1 - Statin therapy decreases N-terminal pro-B-type natriuretic peptide in HIV

T2 - Randomized placebo-controlled trial

AU - Dirajlal-Fargo, Sahera

AU - Kinley, Bruce

AU - Jiang, Ying

AU - Longenecker, Chris T.

AU - Hileman, Corrilynn O.

AU - Debanne, Sara

AU - McComsey, Grace A.

PY - 2014/11/11

Y1 - 2014/11/11

N2 - Objective: HIV-infected participants are at a higher risk for cardiovascular disease (CVD). N-terminal pro-B-type natriuretic peptide (NT-proBNP) is a significant predictor of CVD in the general population and is associated with mortality in HIV.

AB - Objective: HIV-infected participants are at a higher risk for cardiovascular disease (CVD). N-terminal pro-B-type natriuretic peptide (NT-proBNP) is a significant predictor of CVD in the general population and is associated with mortality in HIV.

KW - Cardiovascular disease

KW - Inflammation

KW - N-terminal pro-B-type natriuretic peptide

KW - Statin therapy

UR - http://www.scopus.com/inward/record.url?scp=84927586480&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84927586480&partnerID=8YFLogxK

U2 - 10.1097/QAD.0000000000000547

DO - 10.1097/QAD.0000000000000547

M3 - Article

C2 - 25686680

AN - SCOPUS:84927586480

SN - 0269-9370

VL - 29

SP - 313

EP - 321

JO - AIDS

JF - AIDS

IS - 3

ER -

Statin therapy decreases N-terminal pro-B-type natriuretic peptide in HIV: Randomized placebo-controlled trial

Abstract

Funding

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this